Key result
Initiation of chemotherapy in an 18-year-old male with Epstein-Barr virus (+) natural killer/T-cell lymphoma presenting as acute heart failure led to clinical improvement and resolution of pericardial effusion.
Case Report (n=1)
This case highlights a rare presentation of Epstein-Barr virus (+) natural killer/T-cell lymphoma mimicking acute viral pericarditis and heart failure, emphasizing the importance of tissue biopsy in atypical or refractory cases.
Unexpected lymphoma in presumed viral myopericarditis warrants biopsy in atypical cases; leaves open reversible infiltration as cause of acute biventricular hypertrophy.
An 18-year-old male patient presented to the emergency department complaining of new onset chest pain, fever and orthopnoea. Initial workup was remarkable for elevated troponin, diffuse ST-segment elevation on ECG and chest X-ray with enlarged cardiac silhouette. Transthoracic echocardiogram (TTE) demonstrates severe biventricular concentric hypertrophy and pericardial effusion. Also, Coxsackie virus A and B titres were positive, concerning for a classic viral pericarditis. However, despite medical management, the patient became dyspnoeic and hypotensive. Impending cardiac tamponade was observed on repeat TTE, and pericardiocentesis was performed, complicated by pulseless electrical activity cardiac arrest, and ultimately patient requiring venoarterial extracorporeal membrane oxygenation support. Emergent endomyocardial biopsy showed no inflammatory process, and a skin biopsy of a small lesion in the right arm showed unexpected diagnosis of Epstein-Barr virus (+) natural killer/T-cell lymphoma. On initiation of chemotherapy, clinical improvement was observed as evidenced by improving ejection fraction, resolution of pericardial effusion and gradual decrease in myocardial hypertrophy.
No takes yet. Share an insight, caveat, or question.
Lopez et al. (2020) conducted a case report in Heart failure secondary to Epstein-Barr virus (+) natural killer/T-cell lymphoma (n=1). Chemotherapy was evaluated on Clinical improvement (improving ejection fraction, resolution of pericardial effusion, and gradual decrease in myocardial hypertrophy). Initiation of chemotherapy in an 18-year-old male with Epstein-Barr virus (+) natural killer/T-cell lymphoma presenting as acute heart failure led to clinical improvement and resolution of pericardial effusion.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: